YLYun-Woo Lee

Yun-Woo Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yun-Woo Lee has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hydrogel-Based Micro/Nanorobots for Advanced Biomedical Applications

    by Gyunhee Cho, Jongkuk Ko, Yunwoo Lee

    Micro/nanorobotics is emerging as a promising biomedical technology because of its precision, minimal invasiveness, multifunctionality, and potential to mitigate systemic adverse effects. At these ultraminiaturized scales, unique physical constraints necessitate design principles and actuation strategies distinct from those of conventional robotic systems, making material choice, structural design, propulsion mechanisms, and fabrication methods central to overall performance. In this review, we examine recent trends in micro/nanorobot development, with particular emphasis on the advantages of employing hydrogels and the current technical limitations associated with their use. Magnetic, chemical, acoustic, optical, and biohybrid propulsion strategies are comparatively analyzed, together with the material requirements and biological compatibility associated with each approach. Representative applications in drug delivery, tissue regeneration, and cancer therapy are further discussed to highlight the broad medical potential of these systems. Finally, remaining challenges related to material limitations, actuation efficiency, biocompatibility, and manufacturing scalability are identified, and future directions toward clinical translation and practical deployment are outlined. Overall, this review provides an integrated perspective on how hydrogel properties, actuation physics, fabrication strategies, and translational considerations collectively shape the development of more adaptive, biocompatible, and clinically relevant microrobotic systems.


  • Open Access

    Antibody-Integrated Solid-to-Gel Microfilm for Protection Against Botulinum Neurotoxin Type A

    by Ji-Hwan Ha, Sohee Jeon, Yun-Woo Lee, Soon Hyoung Hwang, Byung-Ho Kang, Young Jo Song, Ji-Su Lim, Hyunbeen Kim, Yoosik Yoon, Jun-Ho Jeong

    Antibodies are indispensable for protection against biological toxins and pathogens, yet their conventional liquid formulations impose severe constraints, including dosing inaccuracy caused by residual fluid remaining in the syringe and limited user convenience such as pain caused by fluid-induced tissue distension and nerve stimulation as well as instability in ambient temperature, and the requirement for low-temperature storage and logistics. These limitations critically impair rapid deployment during golden hour following acute exposure. Here, we report an antibody-integrated solid-to-gel microfilm—demonstrated with a 100 µg anti-BoNT/A dose—jet-printed and low-temperature dried directly onto metal needles for consistent, on-demand use. Upon intradermal insertion, the microfilm fully dissolves within 5 min, driven by hydration-induced swelling of a hyaluronic acid (HA) support layer and rapid release of the antibody. Time-resolved microscopy and UV–vis analysis showed a decrease in residual solid from 2.34 mm3 to 0 over 300 s, with a concomitant rise at 187 nm indicative of complete dissolution. The solid formulation maintained ambient-temperature stability for 3–6 months with pharmacokinetics comparable to conventional subcutaneous liquid injections. In a lethal BoNT/A challenge, treated mice achieved 100% survival for 12 days, whereas controls succumbed within 16 h.